- Report
- February 2025
- 454 Pages
Global
From €4263EUR$4,799USD£3,714GBP
- Report
- February 2025
- 200 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- June 2022
- 55 Pages
Global
From €4397EUR$4,950USD£3,831GBP
- Report
- April 2025
- 175 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- March 2025
- 120 Pages
Global
From €5285EUR$5,950USD£4,605GBP
- Report
- April 2025
- 200 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- November 2024
- 111 Pages
Global
From €4130EUR$4,650USD£3,599GBP
- Report
- March 2025
- 154 Pages
Global
From €4130EUR$4,650USD£3,599GBP
- Report
- August 2024
- 100 Pages
Global
From €4130EUR$4,650USD£3,599GBP
- Report
- March 2024
- 200 Pages
Global
From €3686EUR$4,150USD£3,212GBP
- Report
- December 2023
- 52 Pages
Global
From €4397EUR$4,950USD£3,831GBP
- Report
- December 2022
- 68 Pages
Global
- Report
- February 2024
- 115 Pages
Global
From €4219EUR$4,750USD£3,676GBP
- Report
- April 2025
- 200 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- March 2025
- 175 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- September 2024
- 323 Pages
Global
From €4441EUR$5,000USD£3,869GBP
- Report
- July 2024
- 339 Pages
Global
From €4441EUR$5,000USD£3,869GBP
- Report
- June 2023
- 340 Pages
Global
From €4441EUR$5,000USD£3,869GBP
- Report
- February 2021
Global
From €3953EUR$4,450USD£3,444GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more